- Preview Available
- Scholarly Journal
Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial
Nature Communications; London Vol. 16, Iss. 1, (2025): 4608.
DOI:10.1038/s41467-025-59865-1
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




